Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer-Reference-Cited by-同舟云学术

Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer

Published:2011-06 Issue:3 Volume:13 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Parmar Sumit,Stingl Julia Carolin,Huber-Wechselberger Ariana,Kainz Alexander,Renner Wilfried,Langsenlehner Uwe,Krippl Peter,Brockmöller Jürgen,Haschke-Becher Elisabeth

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2894.pdf

Reference52 articles.

1. Miyoshi Y, Kurosumi M, Kurebayashi J, Matsuura N, Takahashi M, Tokunaga E, Egawa C, Masuda N, Kono S, Morimoto K, Kim SJ, Okishiro M, Yanagisawa T, Ueda S, Taguchi T, Tamaki Y, Noguchi S: Predictive factors for anthracycline-based chemotherapy for human breast cancer. Breast Cancer. 2010, 17: 103-109. 10.1007/s12282-009-0152-6.

2. Ormrod D, Holm K, Goa K, Spencer C: Epirubicin: a review of its efficacy as adjuvant therapy and in the treatment of metastatic disease in breast cancer. Drugs Aging. 1999, 15: 389-416. 10.2165/00002512-199915050-00006.

3. Smith PJ, Soues S: Multilevel therapeutic targeting by topoisomerase inhibitors. Br J Cancer Suppl. 1994, 23: S47-51.

4. Simunek T, Sterba M, Popelova O, Adamcova M, Hrdina R, Gersl V: Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep. 2009, 61: 154-171.

5. Schott B, Robert J: Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture. Biochem Pharmacol. 1989, 38: 4069-4074. 10.1016/0006-2952(89)90688-6.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor;World Journal of Clinical Oncology;2023-09-24

2. Heterodimerization of Human UDP-Glucuronosyltransferase 1A9 and UDP-Glucuronosyltransferase 2B7 Alters Their Glucuronidation Activities;Drug Metabolism and Disposition;2023-08-29

3. Magnetic Solid-Phase Microextraction Protocol Based on Didodecyldimethylammonium Bromide-Functionalized Nanoparticles for the Quantification of Epirubicin in Biological Matrices;Pharmaceutics;2023-04-12

4. The Somatic Mutation Landscape of UDP-Glycosyltransferase (UGT) Genes in Human Cancers;Cancers;2022-11-21

5. DNA Topoisomerase Targeting Drugs;Holland‐Frei Cancer Medicine;2022-10-21